WIC
PFE icon

Woodmont Investment Counsel’s Pfizer PFE Stock Holding History

Woodmont Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85M Buy
284,542
+6,151
+2% +$161K 0.37% 57
2026
Q1 		$7.82M Buy
278,391
+11,490
+4% +$306K 0.48% 49
2025
Q4 		$6.65M Buy
266,901
+11,084
+4% +$280K 0.42% 52
2025
Q3 		$6.52M Buy
255,817
+9,367
+4% +$231K 0.43% 51
2025
Q2 		$5.97M Sell
246,450
-23,531
-9% -$549K 0.39% 54
2025
Q1 		$6.84M Buy
269,981
+16,987
+7% +$445K 0.49% 46
2024
Q4 		$6.71M Buy
252,994
+25,505
+11% +$692K 0.5% 48
2024
Q3 		$6.58M Buy
227,489
+65,424
+40% +$1.91M 0.5% 43
2024
Q2 		$4.53M Buy
162,065
+42,011
+35% +$1.16M 0.37% 55
2024
Q1 		$3.33M Buy
120,054
+12,883
+12% +$357K 0.28% 70
2023
Q4 		$3.09M Sell
107,171
-28,597
-21% -$864K 0.29% 69
2023
Q3 		$4.5M Buy
135,768
+5,428
+4% +$192K 0.48% 51
2023
Q2 		$4.78M Sell
130,340
-1,431
-1% -$55.7K 0.5% 49
2023
Q1 		$5.38M Sell
131,771
-2,291
-2% -$98.9K 0.57% 47
2022
Q4 		$6.87M Sell
134,062
-536
-0.4% -$25.7K 0.78% 39
2022
Q3 		$5.89M Buy
134,598
+8,967
+7% +$436K 0.74% 40
2022
Q2 		$6.59M Buy
125,631
+2,754
+2% +$140K 0.81% 38
2022
Q1 		$6.36M Buy
122,877
+18,672
+18% +$969K 0.73% 36
2021
Q4 		$6.15M Buy
104,205
+1,012
+1% +$50.1K 0.79% 36
2021
Q3 		$4.44M Buy
103,193
+2,012
+2% +$89.1K 0.65% 44
2021
Q2 		$3.96M Buy
101,181
+2,929
+3% +$114K 0.62% 45
2021
Q1 		$3.56M Buy
98,252
+6,362
+7% +$226K 0.61% 46
2020
Q4 		$3.38M Buy
91,890
+4,624
+5% +$170K 0.63% 44
2020
Q3 		$3.04M Buy
87,266
+943
+1% +$33.1K 0.65% 42
2020
Q2 		$2.68M Buy
86,323
+5,170
+6% +$176K 0.64% 45
2020
Q1 		$2.51M Buy
81,153
+14,431
+22% +$492K 0.69% 42
2019
Q4 		$2.48M Buy
66,722
+2,924
+5% +$104K 0.56% 48
2019
Q3 		$2.17M Buy
63,798
+6,626
+12% +$241K 0.53% 50
2019
Q2 		$2.35M Buy
57,172
+948
+2% +$37.6K 0.58% 49
2019
Q1 		$2.27M Buy
56,224
+174
+0.3% +$6.97K 0.59% 49
2018
Q4 		$2.32M Sell
56,050
-6,636
-11% -$275K 0.65% 47
2018
Q3 		$2.62M Sell
62,686
-3,367
-5% -$130K 0.72% 44
2018
Q2 		$2.27M Sell
66,053
-1,251
-2% -$42.8K 0.63% 46
2018
Q1 		$2.27M Sell
67,304
-6,201
-8% -$213K 0.63% 49
2017
Q4 		$2.53M Sell
73,505
-303
-0.4% -$10.3K 0.65% 48
2017
Q3 		$2.5M Sell
73,808
-516
-0.7% -$16.6K 0.68% 47
2017
Q2 		$2.37M Sell
74,324
-50
-0.1% -$1.58K 0.67% 47
2017
Q1 		$2.29M Hold
74,374
– – 0.67% 51
2016
Q4 		$2.29M Buy
74,374
+8,108
+12% +$248K 0.66% 51
2016
Q3 		$2.13M Sell
66,266
-2,011
-3% -$67.2K 0.61% 52
2016
Q2 		$2.28M Buy
68,277
+6,814
+11% +$217K 0.68% 48
2016
Q1 		$1.73M Buy
61,463
+20,609
+50% +$589K 0.52% 60
2015
Q4 		$1.25M Buy
40,854
+2
+0% +$63 0.37% 78
2015
Q3 		$1.22M Buy
40,852
+382
+0.9% +$12.2K 0.37% 77
2015
Q2 		$1.29M Sell
40,470
-4,461
-10% -$145K 0.37% 76
2015
Q1 		$1.48M Sell
44,931
-896
-2% -$28.5K 0.46% 68
2014
Q4 		$1.35M Sell
45,827
-2,375
-5% -$68.1K 0.42% 73
2014
Q3 		$1.35M Sell
48,202
-4,698
-9% -$132K 0.39% 78
2014
Q2 		$1.49M Sell
52,900
-1,485
-3% -$42.3K 0.42% 79
2014
Q1 		$1.66M Sell
54,385
-27,685
-34% -$825K 0.48% 66
2013
Q4 		$2.38M Sell
82,070
-695
-0.8% -$20.2K 0.72% 42
2013
Q3 		$2.26M Sell
82,765
-369
-0.4% -$10K 0.82% 40
2013
Q2 		$2.21M Buy
+83,134
New +$2.3M 0.74% 41

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Woodmont Investment Counsel's PFE Position: Q2 2026 in Review

Woodmont Investment Counsel increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $161K and bringing the position to 284,542 shares worth $6.85M. The position accounts for 0.37% of the portfolio, ranked #57.

Woodmont Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.82M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Woodmont Investment Counsel held 284,542 shares of Pfizer worth $6.85M as of Q2 2026.
  • Woodmont Investment Counsel bought 6,151 Pfizer shares in Q2 2026, an estimated $161K.
  • Pfizer made up 0.37% of Woodmont Investment Counsel's portfolio in Q2 2026, its #57 holding.
  • Woodmont Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Woodmont Investment Counsel's Pfizer position peaked at $7.82M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Woodmont Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.